Understanding the Cell Wall of the Superbug Streptococcus pneumoniae
Dynamics and Regulation of Peptidoglycan Cell Wall Synthesis in the Superbug Streptococcus pneumoniae
This work explores how the bacteria that cause serious infections, like pneumonia, build their protective outer layer, which could help us find new ways to fight them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trustees of Indiana University NIH-funded |
| Lab location | 1 site (Bloomington, United States) |
| Project ID | NIH-11140278 on NIH RePORTER |
What this research studies
We are looking closely at the tough outer shell, called the peptidoglycan cell wall, that protects bacteria like Streptococcus pneumoniae. This wall is essential for the bacteria to survive and cause illness, and it's also where many antibiotics attack. Our goal is to understand exactly how these bacteria build and maintain this wall, especially focusing on the unique ways this 'superbug' does it. By uncovering these building secrets, we hope to discover new weak points that future medicines can target to overcome antibiotic resistance.
Who could benefit from this research
Good fit: This foundational work does not involve direct patient participation but aims to benefit anyone susceptible to or suffering from infections caused by Streptococcus pneumoniae, especially those with antibiotic-resistant strains.
Not a fit: Patients not affected by Streptococcus pneumoniae infections or antibiotic resistance would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to the development of new antibiotics or treatment strategies for infections caused by antibiotic-resistant Streptococcus pneumoniae.
How similar studies have performed: While the specific mechanisms of cell wall synthesis in Streptococcus pneumoniae are still being uncovered, understanding bacterial cell walls has historically been a successful strategy for antibiotic development.
Where this research is happening
Bloomington, United States
- Trustees of Indiana University — Bloomington, United States (Active)
Researchers
- Principal investigator: Winkler, Malcolm E. — Trustees of Indiana University
- Study coordinator: Winkler, Malcolm E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.